MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Cyclerion Therapeutics, Inc. (Nasdaq: CYCN)
Organization & Developments: Cyclerion Therapeutics
Parents
Cyclerion Therapeutics, Inc. (Nasdaq: CYCN)
Children
2020: Cyclerion axes another program as struggles grow for Peter Hecht's Ironwood spinout
2020: Cyclerion Is A Speculative Biotech With A Few Catalysts Approaching
2022: Tour de biotech: Cyclerion peddles through another disease area, laying off 45% amid heel turn toward mitochondria
Leaders in targeted sGC stimulator chemistry and nitric oxide-cGMP pathway pharmacolog
Jumps
Finance & Acquisitions: Cyclerion Therapeutics
Key People: Cyclerion Therapeutics